UPCOMING WEBINAR
July 28, 2026, 12:00pm Eastern Time
Webinar Description:
This webinar will review the evolving role of dose-escalated radiation therapy for pancreatic cancer, with an emphasis on patient selection, technical considerations, treatment delivery, and emerging clinical data supporting ablative SBRT approaches. The discussion will highlight how modern image guidance, motion management, and adaptive radiation therapy may allow safe delivery of higher biologically effective doses in appropriately selected patients.
Educational Objectives:
Describe the rationale for dose escalation in pancreatic cancer and how it may improve local tumor control.
Review patient selection and technical considerations for pancreatic SBRT, including motion management, image guidance, adaptive planning, and organ-at-risk constraints.
Discuss emerging clinical data and ongoing controversies regarding ablative radiation therapy for localized pancreatic cancer.
Advances in the applications, technologies and methodologies of stereotactic radiosurgery/stereotactic body radiation therapy (SRS/SBRT) continue to evolve rapidly and the delivery of treatment has become more complex, making it imperative that oncology professionals remain current in the state-of-the-art techniques. The Radiosurgery Society is committed to providing educational programming that creates a forum for global collaboration to improve professional practice by increasing their level of knowledge, as required to improve competency in the field of oncology.
The target audience includes radiation oncologists, surgeons, medical physicists, nurses, residents, trainees and healthcare providers in the field of SRS/SBRT, radiation oncology and medical oncology.
Pending Review
Pending Review
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-‐6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
<em>No financial commercial support was received for this educational activity.</em>
<em>No in-kind commercial support was received for this educational activity.</em>
If continuing education credits are applicable for this webinar, a certificate will be issued upon completion of course requirements, including the online evaluation, enabling you to register your credit with the appropriate licensing boards or associations. Evaluations must be completed within 45 days of live webinar.
Please contact webinars@therss.org if you have questions.